For research purposes only, such as microscopic examination. Not for human consumption.*

*Research molecules such as Methylcybin, 1cP-LSD and M.esc are not approved for consumption by the Commodities Act (NVWA). Consumers themselves, and no one else, are responsible for conducting research with this substance. Most consumers use it for microscopic examination.

We do not ship this product to countries where this is a controlled substance. Orders from countries where this substance is not legal will be refunded immediately and not shipped.

Methylcybin was first synthesised by US chemist Alexander Shulgin in 1997. This well-known chemist documented this in his 1997 book TiHKAL ("Tryptamines I Have Known and Loved"). Reports of human use surfaced in the late 2000s after it appeared on the online market for research molecules. Other psilocybin analogues such as 4-AcO-DMT and 4-HO-MiPT have similar structures and effects.

Subjective effects include geometric visual hallucinations, time distortion, enhanced introspection and ego loss. Users usually describe 4-HO-MET as a more recreational version of psilocybin mushrooms or psilocin (4-HO-DMT) because of its less serious headspace and greater emphasis on visual effects. The psychedelic images are vivid and colourful.

There are very little data on the pharmacological properties, metabolism and toxicity of Methylcybin. It has a similar risk and toxicity profile to psilocin and 4-AcO-DMT, at least this is assumed, but there are no data to our knowledge to support this yet. For research purposes only, not for human consumption. For microscopic examination only. 

• Threshold: 5 mg
• Light: 5 - 15 mg
• Common: 15 - 25 mg
• Strong: 25 - 45 mg
• Heavy: 45 mg +

• Total: 4 - 6 hours
• Onset: 15 to 30 min